Reference products with biosimilar approvals
STO-REC-STAT60N9V7T1 Official
8
United States · 2024
Reference products with biosimilar approvals in United States stood at 8 in 2024 (FDA).
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- A Record Year for Biosimilar Approvals
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
This milestone is due to CDER approving in 2024 a record total of 18 biosimilars for 8 reference products, more than any previous year.
Verbatim extraction verified: The figure 8 is directly attested in the quoted passage (A Record Year for Biosimilar Approvals).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7
- MLA
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7.
- Chicago
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7.
- BibTeX
- @misc{fda2024reference114pd7, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
- Type
- Press release
- Published
- —
- Locator
- A Record Year for Biosimilar Approvals
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_60N9V7K4M162PZDBQ1S0114PD7